Industry Focus

Activist investors are offering to buy the health records company, but visionary CEO Jonathan Bush might not want to sell. Also, Shire gives the thumbs up to Takeda and patience pays off for Portola Pharmaceuticals investors.

Direct download: 20180509_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST